Breaks Categories: News

WednesdayOct 05, 2016 12:50 pm

eXp World Holdings, Inc. (EXPI) Hosting Sold-Out Real Estate Conference

eXp World Holdings, Inc. (OTCQB: EXPI), owner of cloud-based real estate brokerage firm eXp Realty, recently announced changes to its leadership team as part of its strategy to continue its rapidly growing presence in the real estate market. Indicative of this growth, the company is currently hosting its third annual real estate conference in San Antonio, Texas, which sold out well before its opening. More than 600 of eXp Realty’s brokers and agents are expected to attend the conference, more than three times the number from last year’s event. This year’s conference is taking place October 5-7, 2016. To view…

Continue Reading

WednesdayOct 05, 2016 12:49 pm

Anavex Life Sciences Corp. (AVXL) Teams with Ariana Pharma to Advance Alzheimer’s and Parkinson’s Clinical Development Programs

Anavex Life Sciences (NASDAQ: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, this morning announced its collaboration with Ariana Pharma (Cambridge, MA and Paris, France) in which Anavex will use Ariana’s proprietary, FDA-tested KEM® (Knowledge, Extraction, Management) patient stratification technology to potentially accelerate ANAVEX 2-73’s ongoing phase 2/3 Alzheimer’s clinical development timelines. KEM® is a comprehensive clinical data analysis system that enables full exploitation of complex datasets including of smaller numbers of patients. To view the full press release, visit: http://nnw.fm/4D42d About Anavex Life Sciences Corp. Anavex Life Sciences Corp. (NASDAQ: AVXL)…

Continue Reading

WednesdayOct 05, 2016 12:48 pm

Immunomedics, Inc. (IMMU) Prices Underwritten Offering

Immunomedics (NASDAQ: IMMU) has priced an underwritten offering of 10 million shares of common stock and warrants to purchase up to 10 million shares of common stock at $3 per share for anticipated gross proceeds of $30 million. The company said it will use the proceeds from the offering to support clinical and regulatory activities for IMMU-132, including submission of a New Drug Application to the Food and Drug Administration for accelerated approval in metastatic triple-negative breast cancer, as well as for working capital and general corporate purposes. To view the full press release, visit: http://nnw.fm/vPH7a About Immunomedics, Inc. Immunomedics…

Continue Reading

WednesdayOct 05, 2016 12:46 pm

Innovus Pharmaceuticals, Inc. (INNV) Initiates Safety and Efficacy Study of Vesele® in Combination with Viagra®

Innovus Pharmaceuticals (OTCQB: INNV), a commercial-stage pharmaceutical company focused on over-the-counter medicines and consumer care products for men’s and women's health and respiratory diseases, has initiated a pre-clinical and clinical program to evaluate the safety and efficacy of its supplement Vesele® for promoting sexual health in combination with sildenafil indicated for treating erectile dysfunction. In the U.S., sildenafil is sold under the name Viagra® by Pfizer, Inc. (NYSE: PFE). In a previously announced human clinical survey to evaluate erectile dysfunction and sexual satisfaction in men using Vesele®, the drug showed favorable results. To view the full press release, visit: http://nnw.fm/nCgK6…

Continue Reading

TuesdayOct 04, 2016 12:36 pm

Netlist, Inc. (NLST) Pursues Importation Ban on SK Hynix, Inc. via ITC Investigation

Netlist, Inc. (NASDAQ: NLST) this morning announced that the U.S. International Trade Commission (ITC) is investigating the unfair trade practices of SK Hynix, Inc. related to its importation, sale for importation, and/or sale after importation of RDIMM and LRDIMM enterprise memory products.  The investigation seeks to determine whether these SK hynix products should be banned from importation into the United States by reason of infringement of six Netlist patents. ITC investigations proceed on an expedited basis, commonly progressing to trial within a year. To view the full press release, visit: http://nnw.fm/Uz2u8 About Netlist, Inc. Netlist creates solutions that accelerate turning…

Continue Reading

TuesdayOct 04, 2016 12:34 pm

Cellectar Biosciences, Inc. (CLRB) Granted Patent Allowance for CLR 1603

Cellectar Biosciences (NASDAQ: CLRB), an oncology-focused clinical stage biotech company, this morning announced that it has received from the U.S. Patent and Trademark Office (“USPTO”) a formal patent allowance for CLR 1603, which covers method of use for the treatment of a variety of solid tumors and associated cancer stem cells using the company’s phospholipid drug conjugate (“PDC”) delivery platform technology with paclitaxel.  The USPTO patent allowance covers method of use for breast, pancreatic, lung, colorectal and prostate cancers.  The company expects the full patent to be granted by the end of 2016. Cellectar earlier this year received patent allowance…

Continue Reading

TuesdayOct 04, 2016 11:27 am

Growblox Sciences, Inc. (GBLX) Acquires Two Licenses to Support Medical Cannabis Cultivation and Production

Growblox Sciences (OTCQB: GBLX) this morning reported its acquisition of two additional Medical Marijuana Establishment ("MME") licenses in Clark County, Nevada.  To acquire the licenses, Growblox formed GB Sciences Las Vegas, LLC, for which Growblox will be the owner/operator and own 60% of the entity with the option to own up to 80%.  The production license allows Growblox to convert plants to oil, which can be used to make personal vaporizer pens, gel caps, edibles, beauty aids, cosmetics, pure botanicals, extracts, and other products. The cultivation license expands Growblox’s current Nevada cultivation capacity, which at full production can currently support 4,000…

Continue Reading

MondayOct 03, 2016 12:49 pm

FTE Networks, Inc. (FTNW) Guides for $55M in Revenues on Strong Project Pipeline

FTE Networks (OTCQX: FTNW) this morning provided 12-month revenue guidance and pegged its current contract pipeline at approximately $166 million. The network infrastructure solutions provider said it expects the contracted projects – awarded during the first nine months of 2016 - to generate in excess of $55 million in annualized revenue from 2017 to 2019. "We will continue to see a ramp up in revenues as we head into 2017 and beyond as our new management team works on a number of new higher margin initiatives such as Compute-to-the-Edge which is the next wave of telecom. We are currently engaged…

Continue Reading

MondayOct 03, 2016 11:05 am

Health Advance, Inc. (HADV) to acquire Web Domain DiscountSeniorSupply.com

Health Advance (OTC: HADV) has signed a definitive agreement to acquire web domain www.discountseniorsupply.com and license the interspire e-commerce shopping cart and supplier relationships, as well as a team in India that would manage the e-commerce web business and provide customer support along with marketing reports and updates. Per the agreement, Health Advance will issue 400,000 shares of its common stock and a one-time cash payment of $10,000 representing the total purchase price of DiscountSeniorSupply. The acquisition is expected to close on or before October 31, 2016. To view the full press release, visit: http://nnw.fm/6XtB1 About Health Advance, Inc. Health Advance…

Continue Reading

FridaySep 30, 2016 12:49 pm

Ballard Power Systems (BLDP) Deploys Largest Installment of Fuel Cell Buses in China’s History

Ballard Power Systems (NASDAQ: BLDP) today announced the commissioning and deployment of 12 fuel cell-powered buses in the District of Sanshui, in the City of Foshan, in the Province of Guangdong, China. These initial buses will be operated by Foshan Sanshui Guohong Public Transit Co. Ltd. "In September 2015 we announced the planned deployment of 300 fuel cell-powered buses in Foshan/Yunfu. Our program consortium has made considerable progress over the past year, including localization of Ballard-designed fuel cell engines, establishment of a fuel cell bus manufacturing facility, local procurement activities, development of systems integration capabilities, national permitting of a fuel…

Continue Reading